Works matching AU Wen, Patrick Y
Results: 237
Signal transduction inhibitors and antiangiogenic therapies for malignant glioma.
- Published in:
- Glia, 2011, v. 59, n. 8, p. 1205, doi. 10.1002/glia.21137
- By:
- Publication type:
- Article
The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 8, p. 639, doi. 10.1093/jnci/djk135
- By:
- Publication type:
- Article
Corticosteroid Use in Patients with Glioblastoma at First or Second Relapse Treated with Bevacizumab in the BRAIN Study.
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1329, doi. 10.1634/theoncologist.2010-0105
- By:
- Publication type:
- Article
Intravascular lymphomatosis and intracerebral haemorrhage.
- Published in:
- Neurological Sciences, 2010, v. 31, n. 6, p. 793, doi. 10.1007/s10072-010-0284-7
- By:
- Publication type:
- Article
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma.
- Published in:
- CA: A Cancer Journal for Clinicians, 2010, v. 60, n. 3, p. 166, doi. 10.3322/caac.20069
- By:
- Publication type:
- Article
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
- Published in:
- Journal of Neurosurgery, 2015, v. 122, n. 1, p. 4, doi. 10.3171/2014.7.jns131644
- By:
- Publication type:
- Article
Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors.
- Published in:
- Journal of Neurosurgery, 2013, v. 118, n. 6, p. 1183, doi. 10.3171/2013.1.JNS12397
- By:
- Publication type:
- Article
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3662, doi. 10.1007/s00259-024-06783-x
- By:
- Publication type:
- Article
Glioma resource outreach with support: A program to identify and initiate supportive care interventions for unmet needs among adult lower-grade glioma patients.
- Published in:
- Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 87, doi. 10.1093/nop/npae065
- By:
- Publication type:
- Article
The predictive value of partial MGMT promoter methylation for IDH-wild-type glioblastoma patients.
- Published in:
- Neuro-Oncology Practice, 2023, v. 10, n. 2, p. 126, doi. 10.1093/nop/npac070
- By:
- Publication type:
- Article
Frequency, etiologies, risk factors, and sequelae of falls among patients with brain metastases: A population- and institutional-level analysis.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 2, p. 114, doi. 10.1093/nop/npab061
- By:
- Publication type:
- Article
Emergency department visits and inpatient hospitalizations among older patients with brain metastases: a dual population- and institution-level analysis.
- Published in:
- Neuro-Oncology Practice, 2021, v. 8, n. 5, p. 569, doi. 10.1093/nop/npab029
- By:
- Publication type:
- Article
Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 1, p. 38, doi. 10.1093/nop/npz038
- By:
- Publication type:
- Article
Response Assessment in Neuro-Oncology (RANO): more than imaging criteria for malignant glioma.
- Published in:
- Neuro-Oncology Practice, 2015, v. 2, n. 4, p. 205, doi. 10.1093/nop/npv037
- By:
- Publication type:
- Article
Understanding the patient experience and treatment benefits in patients with non–small‐cell lung cancer with brain metastasis.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 12, p. 13637, doi. 10.1002/cam4.5975
- By:
- Publication type:
- Article
Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 13, p. 5988, doi. 10.1002/cam4.2505
- By:
- Publication type:
- Article
Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32430-w
- By:
- Publication type:
- Article
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy -- detecting illusive disease, defining response.
- Published in:
- Frontiers in Neurology, 2015, v. 6, p. 1, doi. 10.3389/fneur.2015.00033
- By:
- Publication type:
- Article
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 6, p. 895, doi. 10.1111/j.1365-2141.2008.07573.x
- By:
- Publication type:
- Article
Results of Stereotactic Brachytherapy Used in the Initial Management of Patients With Glioblastoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 24, p. 1918
- By:
- Publication type:
- Article
Book Reviews.
- Published in:
- 2005
- By:
- Publication type:
- Book Review
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extent of resection and overall survival for patients with atypical and malignant meningioma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 997, doi. 10.1002/cncr.28935
- By:
- Publication type:
- Article
Recurrent glioblastoma: Volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 19, p. 3479, doi. 10.1002/cncr.28210
- By:
- Publication type:
- Article
Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97454-6
- By:
- Publication type:
- Article
Improved survival among females and association with lymphopenia in patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 2005, doi. 10.1093/neuonc/noac190
- By:
- Publication type:
- Article
Investigational PET tracers in neuro-oncology—What's on the horizon? A report of the PET/RANO group.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 11, p. 1815, doi. 10.1093/neuonc/noac131
- By:
- Publication type:
- Article
Combined immunotherapy with controlled interleukin-12 gene therapy and immune checkpoint blockade in recurrent glioblastoma: An open-label, multi-institutional phase I trial.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 951, doi. 10.1093/neuonc/noab271
- By:
- Publication type:
- Article
Surveillance imaging frequency in adult patients with lower-grade (WHO Grade 2 and 3) gliomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 7, p. 1035, doi. 10.1093/neuonc/noac031
- By:
- Publication type:
- Article
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 6, p. 855, doi. 10.1093/neuonc/noac004
- By:
- Publication type:
- Article
molecularly integrated grade for meningioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 5, p. 796, doi. 10.1093/neuonc/noab213
- By:
- Publication type:
- Article
Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 5, p. 770, doi. 10.1093/neuonc/noab256
- By:
- Publication type:
- Article
Predictors of long-term survival among patients with brain metastases.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 494, doi. 10.1093/neuonc/noab285
- By:
- Publication type:
- Article
Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 289, doi. 10.1093/neuonc/noab151
- By:
- Publication type:
- Article
use of external control data for predictions and futility interim analyses in clinical trials.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 2, p. 247, doi. 10.1093/neuonc/noab141
- By:
- Publication type:
- Article
Corrigendum to: Deep learning-based automatic tumor burden assessment of pediatric high-grade gliomas, medulloblastomas, and other leptomeningeal seeding tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2124, doi. 10.1093/neuonc/noab226
- By:
- Publication type:
- Article
Telomerase as a therapeutic target in glioblastoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2004, doi. 10.1093/neuonc/noab203
- By:
- Publication type:
- Article
SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1835, doi. 10.1093/neuonc/noab152
- By:
- Publication type:
- Article
Epidemiology of brain metastases and leptomeningeal disease.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 9, p. 1447, doi. 10.1093/neuonc/noab101
- By:
- Publication type:
- Article
The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 8, p. 1215, doi. 10.1093/neuonc/noab120
- By:
- Publication type:
- Article
Positron emission tomography imaging of drug concentrations in the brain.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 4, p. 537, doi. 10.1093/neuonc/noab025
- By:
- Publication type:
- Article
Population-based estimates of survival among elderly patients with brain metastases.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 4, p. 661, doi. 10.1093/neuonc/noaa233
- By:
- Publication type:
- Article
Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 506, doi. 10.1093/neuonc/noaa305
- By:
- Publication type:
- Article
A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 468, doi. 10.1093/neuonc/noaa240
- By:
- Publication type:
- Article
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 2, p. 189, doi. 10.1093/neuonc/noaa253
- By:
- Publication type:
- Article
Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 12, p. 1822, doi. 10.1093/neuonc/noaa105
- By:
- Publication type:
- Article